Our patient cohort without ProP1 mutation presented with complete or partial GH deficiency, TSH deficiency (except for S6 and S11 patients), FSH/LH deficiency (except for S5 and S10 patients), and ACTH deficiency (except for the S3 patient). This evidence concerns the gene BRD2 and central congenital hypothyroidism.